News

Refresco Beverages’ $650,000 deal to settle an employee’s class action following a cyberattck on the company’s computer ...
AI industry groups are urging an appeals court to block what they say is th. They've warned that a single lawsuit raised by ...
A proposed class action alleging that video-game retailer Gamestop Inc. used online tracking software to collect consumers’ information in violation of the Pennsylvania Wiretapping and Electronic ...
But the NYT and other news organizations rejected the compromise, OpenAI said in a filing yesterday. Instead, news plaintiffs ...
Current and former AT&T customers may be eligible for compensation after two major data breaches exposed personal information ...
As Ethereum sails into its second decade, facing fierce competition from a sea of rivals, its ultimate advantage may not be its code, but its culture. Kevin Lee describes this as “one of its most ...
Meta has reached a settlement with its shareholders and company leadership, thereby avoiding an $8 billion trial.
According to OpenAI CEO Sam Altman, the AI industry hasn’t yet figured out how to protect user privacy when it comes to these more sensitive conversations, because there’s no doctor-patient ...
ChatGPT users laying it all out on the couch could see their chatbot therapy sessions uncovered if OpenAI were hit with a lawsuit, says Sam Altman.
By Adriano Marchese Biopharmaceutical company Quantum BioPharma said it has acquired 2,000 shares of specialty games and entertainment retailer GameStop in what it calls a strategic investment.
Forward-looking statements include the Company’s belief that its investment in GameStop represents a strategic opportunity and its expectation of a potential increase in GameStock’s stock price.